发明申请
US20080292583A1 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione following autologous stem cell transplantation 有权
自体干细胞移植后使用3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基) - 哌啶-2,6-二酮治疗多发性骨髓瘤的方法

  • 专利标题: Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione following autologous stem cell transplantation
  • 专利标题(中): 自体干细胞移植后使用3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基) - 哌啶-2,6-二酮治疗多发性骨髓瘤的方法
  • 申请号: US12151758
    申请日: 2008-05-08
  • 公开(公告)号: US20080292583A1
    公开(公告)日: 2008-11-27
  • 发明人: Jerome B. Zeldis
  • 申请人: Jerome B. Zeldis
  • 专利权人: Celgene Corporation
  • 当前专利权人: Celgene Corporation
  • 主分类号: A61K31/45
  • IPC分类号: A61K31/45 A61K38/20 A61K38/21 A61K38/18 A61P35/00
Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione following autologous stem cell transplantation
摘要:
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
信息查询
0/0